Guardian Partners
ABVX icon

Guardian Partners’s Abivax ABVX Stock Holding History

Guardian Partners’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$515K Buy
5,200
+2,500
+93% +$301K 0.05% 155
2026
Q2 		$360K Hold
2,700
– – 0.03% 166
2026
Q1 		$301K Buy
+2,700
New +$320K 0.03% 169

Other funds holding ABVX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return

Guardian Partners's ABVX Position: Q3 2026 in Review

Guardian Partners increased its Abivax (ABVX) stake by 93% in Q3 2026, buying an estimated $301K and bringing the position to 5,200 shares worth $515K. The position accounts for 0.05% of the portfolio, ranked #155.

Guardian Partners first reported a position in ABVX in Q1 2026 and has held it in 3 quarters since. 94 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Guardian Partners held 5,200 shares of Abivax worth $515K as of Q3 2026.
  • Guardian Partners bought 2,500 Abivax shares in Q3 2026, an estimated $301K.
  • Abivax made up 0.05% of Guardian Partners's portfolio in Q3 2026, its #155 holding.
  • Guardian Partners first reported a position in Abivax in Q1 2026 and has held it in 3 quarters since.
  • 94 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Guardian Partners's 13F filing for Q3 2026, filed 21 Oct 2026.